Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 10, 2026 · Charter amendment · Item 5.07 · Financial statements
Enliven Therapeutics, Inc.
8
Charter amendment
Jun 10, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Charter amendment · Item 5.07 · Financial statements |
| Primary topic | Charter amendment |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Enliven Therapeutics, Inc. filed this 8-K to disclose: ) 205 Park Road Burlingame , CA 94010 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: 650 - 547-5814 6200 Lookout Road Boulder , Colorado 80301 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the f… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 9, 2026 |
| Accession number | 0001193125-26-264085 |
| Reported items | Amended articles of incorporation or bylaws, Item 5.07, Financial statements and exhibits See Analysis tab for workforce implications |
